0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

The Weight-based Heparin Dosing Nomogram Compared with a Standard Care Nomogram: A Randomized Controlled Trial

Robert A. Raschke, MD, MS; Brendan M. Reilly, MD; James R. Guidry, PharmD, BCPS; Joseph R. Fontana, MD; and Sandhya Srinivas, MD
[+] Article and Author Information

From Good Samaritan Regional Medical Center, Phoenix, Arizona; the University of Rochester School of Medicine, Rochester, New York; St. Mary's Hospital, Rochester, New York. Requests for Reprints: Robert A. Raschke, MD, Department of Medicine, Good Samaritan Regional Medical Center, 1111 E. McDowell Road, Phoenix, AZ 85006. Acknowledgments: The authors thank Drs. Alvin Mushlin, Barbara Weber, and Michael Wagner for their review of the manuscript and Dr. Philip C. Comp and Toppy Nelson for performing anti-factor Xa assays. Grant Support: By The Palms Clinic, Phoenix, Arizona.


Copyright 2004 by the American College of Physicians


Ann Intern Med. 1993;119(9):874-881. doi:10.7326/0003-4819-119-9-199311010-00002
Text Size: A A A

Objective: To determine whether an intravenous heparin dosing nomogram based on body weight achieves therapeutic anticoagulation more rapidly than a standard care nomogram.

Design: Randomized controlled trial.

Setting: Two community teaching hospitals in Phoenix, Arizona, and Rochester, New York.

Participants: One hundred fifteen patients requiring intravenous heparin treatment for venous or arterial thromboembolism or for unstable angina.

Intervention: Patients were randomized to the weight-based nomogram (starting dose, 80 units/kg body weight bolus, 18 units/kg per hour infusion) or the standard care nomogram (starting dose, 5000-unit bolus, 1000 units per hour infusion). Activated partial thromboplastin time (APTT) values were monitored every 6 hours, and heparin dose adjustments were determined by the nomograms.

Measurements: Activated partial thromboplastin times were measured using a widely generalizable laboratory method. The primary outcomes were the time to exceed the therapeutic threshold (APTT > 1.5 times the control) and the time to achieve therapeutic range (APTT, 1.5 to 2.3 times the control). Bleeding complications and recurrent thromboembolism were also compared.

Results: Kaplan-Meier curves for the primary outcomes favored the weight-based nomogram (P < 0.001 for both). In the weight-based heparin group, 60 of 62 patients (97%) exceeded the therapeutic threshold within 24 hours, compared with 37 of 48 (77%) in the standard care group (P < 0.002). Only one major bleeding complication occurred (in a standard care patient). Recurrent thromboembolism was more frequent in the standard care group; relative risk, 5.0 (95% CI, 1.1 to 21.9).

Conclusions: The weight-based heparin nomogram is widely generalizable and has proved to be effective, safe, and superior to one based on standard practice.

Figures

Grahic Jump Location
Figure 1.
Kaplan-Meier curve for the heparin therapeutic threshold.P

The weight-based nomogram achieved an activated partial thromboplastin time above the therapeutic threshold more rapidly ( < 0.001). APT = activated partial thromboplastin time.

Grahic Jump Location
Grahic Jump Location
Figure 2.
Kaplan-Meier curve for the therapeutic range of heparin.P

The weight-based nomogram achieved an activated partial thromboplastin time within the therapeutic range (1.5 to 2.3 times the control) more rapidly ( < 0.001). APT = activated partial thromboplastin time.

Grahic Jump Location
Grahic Jump Location
Figure 3.
A sample weight-based heparin order sheet. APTT = activated partial thromboplastin time.
Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)